Marker Therapeutics Inc (MRKR)
3.70
+0.18
(+5.11%)
USD |
NASDAQ |
Nov 05, 16:00
3.70
0.00 (0.00%)
After-Hours: 18:53
Marker Therapeutics Enterprise Value: 23.61M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 23.61M |
| November 01, 2024 | 24.86M |
| October 31, 2024 | 28.34M |
| October 30, 2024 | 28.51M |
| October 29, 2024 | 28.69M |
| October 28, 2024 | 30.75M |
| October 25, 2024 | 30.79M |
| October 24, 2024 | 27.98M |
| October 23, 2024 | 32.44M |
| October 22, 2024 | 32.71M |
| October 21, 2024 | 25.21M |
| October 18, 2024 | 23.61M |
| October 17, 2024 | 21.20M |
| October 16, 2024 | 23.61M |
| October 15, 2024 | 21.38M |
| October 14, 2024 | 22.45M |
| October 11, 2024 | 16.38M |
| October 10, 2024 | 14.42M |
| October 09, 2024 | 15.58M |
| October 08, 2024 | 15.67M |
| October 07, 2024 | 17.00M |
| October 04, 2024 | 17.18M |
| October 03, 2024 | 15.88M |
| October 02, 2024 | 15.31M |
| October 01, 2024 | 16.38M |
| Date | Value |
|---|---|
| September 30, 2024 | 17.36M |
| September 27, 2024 | 18.08M |
| September 26, 2024 | 16.74M |
| September 25, 2024 | 15.22M |
| September 24, 2024 | 15.93M |
| September 23, 2024 | 15.40M |
| September 20, 2024 | 18.43M |
| September 19, 2024 | 18.34M |
| September 18, 2024 | 16.92M |
| September 17, 2024 | 17.09M |
| September 16, 2024 | 17.90M |
| September 13, 2024 | 16.95M |
| September 12, 2024 | 16.29M |
| September 11, 2024 | 17.00M |
| September 10, 2024 | 16.29M |
| September 09, 2024 | 19.71M |
| September 06, 2024 | 18.79M |
| September 05, 2024 | 20.13M |
| September 04, 2024 | 19.68M |
| September 03, 2024 | 19.32M |
| August 30, 2024 | 24.41M |
| August 29, 2024 | 23.43M |
| August 28, 2024 | 23.79M |
| August 27, 2024 | 24.50M |
| August 26, 2024 | 25.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.48M
Minimum
Feb 23 2022
231.02M
Maximum
Jun 14 2021
45.11M
Average
29.63M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.843M |
| Perspective Therapeutics Inc | 530.78M |
| Protalix BioTherapeutics Inc | 69.53M |
| Electromed Inc | 180.63M |
| Armata Pharmaceuticals Inc | 170.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.193M |
| Total Expenses (Quarterly) | 2.308M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -31.89% |
| Normalized Earnings Yield | -138.22 |